About Us  |  BVA-100  |  Investor Relations  |  Idant Division  |  Contact Us
 

Welcome to Daxor!

 
 

2/3/2010 - Presentation of Five Research Reports Involving Daxor's Blood Volume Analyzer at the 39th Annual Society of Critical Care Medicine Conference. Part 2: Direct Blood Volume Measurement Correlated With Improved Survival

  

1/22/2010 - 5 Major Research Reports from Studies Using Daxor's Blood Volume Analyzer Presented at the 39th Annual Society of Critical Care Medicine Conference. Part I: Studies on Leaky Capillary Syndrome

  

12/1/2009 - Daxor Announces that Medical University of South Carolina in Charleston Purchases Blood Volume Analyzer BVA-100

  
 

______________________

 
     
  2009 Second Quarter Earnings  
  June 2009 10-Q  
  2009 Proxy Statement  
  2008 Annual Report  
  2008 Form 10-K  
 

Daxor Corporation is an innovative medical instrumentation and biotechnology company. Daxor designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.


The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

 

Find out more about the BVA-100 >

 

See where blood volume tests are being performed >

 

Watch San Antonio's KENS5 station feature on the BVA-100
(MPEG video; 19 MB) >


 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2009 Daxor Corporation. All Rights Reserved.